Avicanna Announces Changes of Auditors
TORONTO, Aug. 02, 2024 (GLOBE NEWSWIRE) — Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a…
Pharmaceuticals, Biotechnology and Life Sciences
TORONTO, Aug. 02, 2024 (GLOBE NEWSWIRE) — Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a…
/Not for distribution to U.S. news wire services or for dissemination in the United States/ VANCOUVER, British Columbia, Aug. 02,…
Phase 2 TRANQUILITY trial is evaluating the high-sensitivity C-reactive protein (hs-CRP)-lowering effect, safety, tolerability, and pharmacokinetics (PK) of quarterly and…
Funding Extends Company’s Cash Runway into Second Quarter 2025, which is beyond the Anticipated Timing for SHIELD II Top-line Results…
MALVERN, Pa., July 31, 2024 (GLOBE NEWSWIRE) — Ocugen, Inc. (Nasdaq: OCGN), a biotechnology company focused on discovering, developing, and…
Ryoncil BLA Submission Under FDA Review for Approval in Children with SR-aGVHDNEW YORK, July 30, 2024 (GLOBE NEWSWIRE) — Mesoblast…
Châtillon, France, July 30, 2024 DBV Technologies Announces Filing of 2024 Half-Year Report ― Conditions for Accessing or Consulting the…
DEER PARK, Ill., July 30, 2024 (GLOBE NEWSWIRE) — Eton Pharmaceuticals, Inc. (“Eton” or the “Company”) (Nasdaq: ETON), an innovative…
51% of No Tau / Low Tau Patients Showed Improved Cognition and Function Over Three Years; Only Lecanemab Has Clinical…
Expanding Capabilities and Streamlining Experimental WorkflowsFREMONT, Calif., July 30, 2024 (GLOBE NEWSWIRE) — Today Cytek Biosciences, Inc. (Nasdaq: CTKB) announced…